Fever, Shock, and a Rash: Sepsis or MIS-C?
A 6-year-old (22 kg) is admitted with 6 days of fever to 39.5 degrees Celsius, bilateral non-exudative conjunctivitis, a polymorphous rash, cracked lips, abdominal pain, and vomiting. HR 148, BP 72/42 mmHg, capillary refill 4 seconds, extremities warm. Labs: CRP 220 mg/L, ferritin 850 ng/mL, NT-proBNP 7200 pg/mL, troponin I 0.9 ng/mL, platelets 88,000/microliter, sodium 129 mmol/L, lymphocytes 0.6 x 10^9/L, lactate 3.8 mmol/L. Urinalysis is sterile; chest radiograph shows a small effusion and mild pulmonary edema; blood cultures are pending. Echocardiogram shows ejection fraction 40% with mild coronary dilation (z-score 2.3). The emergency department has given 20 mL/kg of balanced crystalloid and he remains hypotensive with new crackles.
1. In the first hour, how do you simultaneously treat possible bacterial sepsis and possible MIS-C? Separate the actions that are non-negotiable from those that can reasonably wait or be sequenced.
Read the worked answer
Non-negotiable in the first hour: obtain blood cultures (and urine, and any focal source) without delaying antibiotics; give broad-spectrum empiric antibiotics within 60 minutes, with coverage chosen for the local epidemiology, typically a third-generation cephalosporin plus anti-staphylococcal coverage given the shock state; stop further fluid boluses given the new crackles, hepatomegaly risk, and known cardiac dysfunction, and if volume is needed use 5-10 mL/kg aliquots with rapid reassessment; start a vasoactive infusion (epinephrine for the cold, myocardial-depressed picture, or norepinephrine if vasodilated); admit to intensive care with continuous cardiac monitoring; obtain ECG and repeat echocardiography.
Sequenced rather than immediate: the ferritin, repeat inflammatory markers, and procalcitonin are useful for pattern recognition but must not delay treatment. IVIG and corticosteroids for MIS-C should not wait for culture results if the phenotype is convincing and shock persists, but they should not be given as reflex before antibiotics are started, because steroids in undifferentiated bacterial shock without vasopressor dependence are associated with harm. The key discipline is that these two pathways are not mutually exclusive; the error is choosing one and neglecting the other.
2. Which findings would move you toward bacterial sepsis rather than MIS-C, and how does that distinction change management in practice?
Read the worked answer
Favoring bacterial sepsis: an indwelling device, immunosuppression, recent surgery, or a focal source (pneumonia, urinary tract infection, osteomyelitis); marked leukocytosis with bandemia or profound leukopenia; a very high procalcitonin; progression over hours rather than a week-long febrile course; and absence of the mucocutaneous and gastrointestinal constellation.
Favoring MIS-C: persistent fever beyond 4 days, conjunctivitis, rash, cracked lips, abdominal pain and vomiting, lymphopenia, thrombocytopenia, hyponatremia, markedly elevated ferritin and NT-proBNP relative to troponin, coronary dilation with a z-score of 2 or more, and the characteristic age group.
Why it matters practically, even though the first hour looks identical: it changes steroid timing and dose, the need for IVIG and antiplatelet therapy, the duration and de-escalation of antibiotics, the intensity of serial echocardiography and ECG monitoring, and the need for isolation and public-health reporting. It also changes the family conversation: one diagnosis has a defined antimicrobial course, the other is an immune-mediated illness that can recur or be followed by coronary aneurysms requiring months of surveillance.
3. Outline your immunomodulation and antithrombotic plan and name the complications that monitoring must catch, including why the IVIG dose itself is a hazard in this child.
Read the worked answer
Immunomodulation: IVIG 2 g/kg as a single infusion over 12-24 hours, plus methylprednisolone 1-2 mg/kg/day, with pulse dosing (10-30 mg/kg/day for 3 days) reserved for severe disease or shock. If fever and inflammation persist despite both, consider anakinra, particularly with features of macrophage activation.
Antithrombotic therapy: low-dose aspirin (3-5 mg/kg/day) for antiplatelet effect once platelets are adequate and bleeding risk is acceptable. Therapeutic anticoagulation is added when the ejection fraction is below about 35%, when coronary z-scores are 2.5 or greater, or when a giant aneurysm is present. This child at 40% with z-score 2.3 is borderline, so the decision should be individualized and revisited as the echo evolves.
Monitoring must catch: (1) worsening systolic function, which changes anticoagulation and escalation decisions, with echo at admission, 48 hours, and 1-2 weeks; (2) arrhythmia and atrioventricular block, via continuous ECG; (3) macrophage activation syndrome, tracked with ferritin, triglycerides, fibrinogen, and serial blood counts; (4) fluid overload, because 2 g/kg of IVIG is roughly 440 mL of a 10% solution in a child with an ejection fraction of 40% and pulmonary edema, so the infusion rate, concurrent diuresis, and respiratory status need active management.